Post by PressReleaseon Jun 17, 2022 6:45am
12 Views
Post# 34763656
New Press Release - Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain